Evidence map›Paper›PMID 37894045›Full record

ReviewMicroorganisms2023

The Low-FODMAP Diet, IBS, and BCFAs: Exploring the Positive, Negative, and Less Desirable Aspects-A Literature Review.

Maroulla D Nikolaki, Arezina N Kasti, Konstantinos Katsas, Konstantinos Petsis, Sophia Lambrinou, Vasiliki Patsalidou, Sophia Stamatopoulou, Katerina Karlatira, John Kapolos, Konstantinos Papadimitriou and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. AnmSystems · 2026
    Article
  6. Article
  7. The Role ofPathogens (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Maroulla D NikolakiDepartment of Nutrition and Dietetics, ATTIKON University General Hospital, 12462 Athens, Greece.ORCID 0000-0002-0546-722X
Arezina N KastiDepartment of Nutrition and Dietetics, ATTIKON University General Hospital, 12462 Athens, Greece.ORCID 0000-0001-7282-4939
Konstantinos KatsasDepartment of Nutrition and Dietetics, ATTIKON University General Hospital, 12462 Athens, Greece.ORCID 0000-0002-3327-9330
Konstantinos PetsisDepartment of Nutrition and Dietetics, ATTIKON University General Hospital, 12462 Athens, Greece.ORCID 0000-0003-3632-2127
Sophia LambrinouDepartment of Clinical Nutrition & Dietetics, General Hospital of Karpathos "Aghios Ioannis o Karpathios", 85700 Karpathos, Greece.ORCID 0000-0003-2475-3472
Vasiliki PatsalidouDepartment of Nutrition and Dietetics, ATTIKON University General Hospital, 12462 Athens, Greece.
Sophia StamatopoulouDepartment of Nutrition and Dietetics, ATTIKON University General Hospital, 12462 Athens, Greece.
Katerina KarlatiraDepartment of Nutrition and Dietetics, ATTIKON University General Hospital, 12462 Athens, Greece.
John KapolosDepartment of Food Science and Technology, University of Peloponnese, 24100 Kalamata, Greece.
Konstantinos PapadimitriouLaboratory of Food Quality Control and Hygiene, Department of Food Science and Human Nutrition, Agricultural University of Athens, 11855 Athens, Greece.ORCID 0000-0002-9614-6543
Konstantinos TriantafyllouHepatogastroenterology Unit, 2nd Department of Internal Propaedeutic Medicine, Medical School, National and Kapodistrian University of Athens, ATTIKON University General Hospital, 12462 Athens, Greece.ORCID 0000-0002-5183-9426
University General Hospital Attikon · GRAgricultural University of Athens · GRHellenic Mediterranean University · GRNational and Kapodistrian University of Athens · GRUniversity of Peloponnese · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The literature about the association of branched short-chain fatty acids (BCFAs) and irritable bowel syndrome (IBS) is limited. BCFAs, the bacterial products of the catabolism of branched-chain amino acids, are proposed as markers for colonic protein fermentation. IBS is a gastrointestinal disorder characterized by low-grade inflammation and intestinal dysbiosis. The low-FODMAP diet (LFD) has increasingly been applied as first-line therapy for managing IBS symptoms, although it decreases the production of short-chain fatty acids (SCFA), well known for their anti-inflammatory action. In parallel, high protein consumption increases BCFAs. Protein fermentation alters the colonic microbiome through nitrogenous metabolites production, known for their detrimental effects on the intestinal barrier promoting inflammation.

Indexed as

branched-chain fatty acidsgut microbiotainflammationirritable bowel syndromelow-FODMAP dietshort-chain fatty acids

Identifiers

PMID37894045
PMCPMC10609264
OpenAlexW4387056319

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.